Recorded onsite at SLAS2023 in San Diego, California, podcast Editor Rob Howes speaks with Davide Gianni, Ph.D. (AstraZeneca) to learn more about Gianni's protocol paper, "A multi-parametric high throughput assay for detecting beta-cell prolife

Behind the Article: A Perspective on the Discovery of Enzyme Activators

Mar 29th, 2023 9m 45s

Welcome to the SLAS Discovery Author Insights podcast! Today we are joined by Antonia Turberville and Geoffrey A. Holdgate to discuss their recent perspective article titled "A perspective on the discovery of enzyme activators". This article sh

New at SLAS: Protocols In Drug Discovery

Feb 22nd, 2023 12m 57s

Traditionally, SLAS Discovery has focused on publishing original research papers and reviews. With the introduction of this latest special issue, the journal is expanding its scope to include protocol articles. These articles are designed to pr

Behind the Scenes at SLAS Europe: Special Interview with Jonathan Wingfield

Sep 21st, 2022 12m 25s

Tune in to this special episode of SLAS Discovery Author Insights, recorded onsite at SLAS Europe in Dublin, Ireland. Join podcast Editor Rob Howes as he chats with Jonathan Wingfield, Ph.D. (AstraZeneca UK) about the return to in-person meetin

Behind the Scenes at SLAS Europe: Special Interview with Timothy Spicer

Jul 20th, 2022 15m 21s

Tune in to this special episode of SLAS Discovery Author Insights, which was recorded onsite at SLAS Europe in Dublin, Ireland. Join podcast Editor Rob Howes as he chats with Timothy Spicer, Ph.D. (Scripps Florida) about his myriad roles within

Special Issue: 3D Cell Culture Approaches of Microphysiologically Relevant Models

Apr 27th, 2022 15m 31s

Volume 27 Issue 3, April 2022Behind April's Special Issue: Join podcast host Rob Howes (Rosalind Franklin Laboratory) as he invites Guest Editor Glauco Souza (Greiner Bio-One) to discuss the special issue covering 3D Cell Culture. They cover th

SLAS Discovery x Assay Guidance Manual: Robust or Go Bust

Dec 15th, 2021 19m 32s

SLAS Discovery Editor-in-Chief Bob Campbell (Twentyeight-seven Therapeutics) welcomes Sarine Markossian, Ph.D. (National Center for Advancing Translational Sciences (NCATS)) and G. Sitta Sittampalam, Ph.D. (National Center for Advancing Transla

In Conversation: SLAS Editors on Open Access

Oct 27th, 2021 13m 38s

Join Jill Hronek, SLAS Director of Marketing and Communications, and Ally Jump, SLAS Publishing Manager, as they speak with SLAS Discovery and SLAS Technology’s respective Editors-in-Chief, Robert M. Campbell, Ph.D., (Twentyeight-Seven Therapeu

Special Issue: Applications of Biophysics in Early Drug Discovery

Sep 22nd, 2021 14m 3s

Podcast Editor Rob Howes chats with Geoffrey A. Holdgate, Ph.D. (AstraZeneca) and Christian Bergsdorf, Ph.D. (Novartis), Guest Editors of the Special Collection: Applications of Biophysics in Early Drug Discovery. This special collection explor

Approaches for Prioritizing High-Quality Chemical Matter in Chemical Probe and Drug Discovery

Aug 18th, 2021 19m 8s

Volume 26 Issue 7, August 2021Podcast Editor Rob Howes chats with Jayme L. Dahlin, MD, Ph.D. (National Center for Advancing Translational Sciences (NCATS)), Guest Editor of the Special Collection: Approaches for Prioritizing High-Quality Chemic

Special Issue: Advances in Protein Degradation

Jun 30th, 2021 24m 37s

Volume 26 Issue 4, April 2021Podcast Editor Rob Howes discusses the SLAS Discovery Special Issue on Advances in Protein Degradation with guest editors Paola Castaldi and Stewart Fisher. Targeted protein degradation has generated interest within

Selecting Approaches for Hit Identification and Increasing Options by Building the Efficient Discovery of Actionable Chemical Matter from DNA-Encoded Libraries

Jan 13th, 2021 32m 31s

Volume 25 Issue 2, February 2021Podcast Editor Rob Howes chats with Marie-Claire Peakman, Ph.D. (Executive Director, Discovery Sciences, Pfizer), author of the featured paper "Selecting Approaches for Hit Identification and Increasing Options b

High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2

Nov 18th, 2020 11m 22s

SLAS Discovery 25.10 December 2020Rob Howes discusses the paper "High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2" with authors Meredith Gardner (Scripps Research) and Michael Farzan (Scripps Research). This r

Comparison of Cell and Organoid-Level Analysis of Patient-Derived 3D Organoids to Evaluate Tumor Cell Growth Dynamics and Drug Response

Jul 23rd, 2020 7m 53s

Volume 25 Issue 7, August 2020Podcast Editor Rob Howes talks with author Seungil Kim about his Open Access original research, "Comparison of Cell and Organoid-Level Analysis of Patient-Derived 3D Organoids to Evaluate Tumor Cell Growth Dynamics

Special Issue: Functional Genomics for Target Identification

Jun 23rd, 2020 13m 14s

Volume 25 Issue 6, July 2020Podcast Editor Rob Howes discusses the SLAS Discovery 2020 July Special Issue with Guest Editors Davide Gianni and Stuart Farrow.This Special Issue of SLAS Discovery presents the topic “Functional Genomics for Target

Special Collection: Ion Channels and Relevant Drug Screening Approaches

Jun 1st, 2020 6m 21s

Volume 25 Issue 5, June 2020Podcast Editor Rob Howes discusses the SLAS Discovery 2020 June Special Collection with SLAS Discovery Editorial Board Member Joseph G. McGivern. To read the editorial by Joseph G. McGivern and Mei Ding, click here.T

Special Issue: Advances in Cellular Target Engagement and Target Deconvolution

Feb 1st, 2020 21m 59s

Volume 25 Issue 2, February 2020Podcast Editor Rob Howes discusses the SLAS Discovery 2020 February Special Issue with Martin Main and Andrew Zhang. To read their editorial, click here. In this Special Issue of SLAS Discovery, the authors explo

Meet Editor-in-Chief Bob Campbell and SLAS Discovery!

Jan 1st, 2020 11m 8s

Robert M. Campbell, Ph.D., is Senior Research Advisor at Eli Lilly and Company in Indianapolis, IN, where he heads the Cancer Cell Growth and Epigenetics Group. Dr. Campbell has served as Editor-in-Chief of SLAS Discoveryfor the past 12 years,

Rate